Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery
Authors:
- Yu-Ling ChangYCYu-Ling Chang
- Min-Shan ChenMCMin-Shan Chen
- Han-Chung WuHWHan-Chung Wu
- 1 April 2011
- journal article
- Published by Elsevier in Biomaterials
- Vol. 32 (12) , 3265-3274
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tissue-Penetrating Delivery of Compounds and Nanoparticles into TumorsCancer Cell, 2009
- A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung CancerPLOS ONE, 2009
- Peptide-Mediated Targeting to Tumor Blood Vessels of Lung Cancer for Drug DeliveryCancer Research, 2007
- Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cellsMolecular Cancer Therapeutics, 2007
- Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent TherapyChest, 2007
- Recent advances with liposomes as pharmaceutical carriersNature Reviews Drug Discovery, 2005
- High interstitial fluid pressure — an obstacle in cancer therapyNature Reviews Cancer, 2004
- Tumor targeting using anti-her2 immunoliposomesJournal of Controlled Release, 2001
- Lung cancerCancer, 1995
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proceedings of the National Academy of Sciences, 1991